Published in PLOS Pathogens · View the paper (DOI)
Researchers found that matrix metalloproteinase (MMP) inhibitors improve blood vessel health at the sites of tuberculosis infection, enhancing delivery and retention of standard drugs. This synergy revitalize current TB treatment and reduce the risk of multi-drug resistant strains.
Coverage from 2 institutions